Cargando…
Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome
AIM: The goal of the study was to detect the presence of macrophage inflammatory protein (MIP)-1α and MIP-1β and to estimate their levels in gingival crevicular fluid (GCF) of children with Down syndrome. MATERIALS AND METHODS: MIP-1α and MIP-1β levels were estimated in GCF samples of 20 healthy and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212665/ https://www.ncbi.nlm.nih.gov/pubmed/30397372 http://dx.doi.org/10.5005/jp-journals-10005-1528 |
_version_ | 1783367589232115712 |
---|---|
author | Reddy, Veerakishore K Kommineni, Naveen K Padakandla, Prathyusha Togaru, Harshini Indupalli, John P Nanga, Swapna P |
author_facet | Reddy, Veerakishore K Kommineni, Naveen K Padakandla, Prathyusha Togaru, Harshini Indupalli, John P Nanga, Swapna P |
author_sort | Reddy, Veerakishore K |
collection | PubMed |
description | AIM: The goal of the study was to detect the presence of macrophage inflammatory protein (MIP)-1α and MIP-1β and to estimate their levels in gingival crevicular fluid (GCF) of children with Down syndrome. MATERIALS AND METHODS: MIP-1α and MIP-1β levels were estimated in GCF samples of 20 healthy and 20 Down syndrome individuals. Gingival status was assessed by measuring the gingival index (GI), plaque index (PI), clinical attachment level (CAL), and probing pocket depth (PPD). The GCF samples were obtained from the subjects and MIP-1α and MIP-1β levels were quantified by enzyme-linked immunosorbent assay (ELISA). RESULTS: The mean MIP-1α concentrations in healthy and Down syndrome individuals were 209 and 1411 pg/μL respectively, and MIP-1α levels were 342 and 1404 pg/μL respectively. The levels of MIP-1α and MIP-1β in the GCF of subjects with Down syndrome were significantly higher than in the healthy individual, and statistically significant differences were present among the two groups. CONCLUSION: The GCF showed dynamic changes according to the severity of periodontal disease, and the levels of MIP-1α and MIP-1β had a strong relationship with clinical parameters. The MIP-1α and MIP-1β can therefore be considered as novel biomarkers in the biological mechanism underlying the patho-genesis of periodontal disease. How to cite this article: Reddy VK, Kommineni NK, Padakandla P, Togaru H, Indupalli JP, Nanga SP. Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome. Int J Clin Pediatr Dent 2018;11(4):288-293. |
format | Online Article Text |
id | pubmed-6212665 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-62126652018-11-05 Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome Reddy, Veerakishore K Kommineni, Naveen K Padakandla, Prathyusha Togaru, Harshini Indupalli, John P Nanga, Swapna P Int J Clin Pediatr Dent Original Article AIM: The goal of the study was to detect the presence of macrophage inflammatory protein (MIP)-1α and MIP-1β and to estimate their levels in gingival crevicular fluid (GCF) of children with Down syndrome. MATERIALS AND METHODS: MIP-1α and MIP-1β levels were estimated in GCF samples of 20 healthy and 20 Down syndrome individuals. Gingival status was assessed by measuring the gingival index (GI), plaque index (PI), clinical attachment level (CAL), and probing pocket depth (PPD). The GCF samples were obtained from the subjects and MIP-1α and MIP-1β levels were quantified by enzyme-linked immunosorbent assay (ELISA). RESULTS: The mean MIP-1α concentrations in healthy and Down syndrome individuals were 209 and 1411 pg/μL respectively, and MIP-1α levels were 342 and 1404 pg/μL respectively. The levels of MIP-1α and MIP-1β in the GCF of subjects with Down syndrome were significantly higher than in the healthy individual, and statistically significant differences were present among the two groups. CONCLUSION: The GCF showed dynamic changes according to the severity of periodontal disease, and the levels of MIP-1α and MIP-1β had a strong relationship with clinical parameters. The MIP-1α and MIP-1β can therefore be considered as novel biomarkers in the biological mechanism underlying the patho-genesis of periodontal disease. How to cite this article: Reddy VK, Kommineni NK, Padakandla P, Togaru H, Indupalli JP, Nanga SP. Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome. Int J Clin Pediatr Dent 2018;11(4):288-293. Jaypee Brothers Medical Publishers 2018 2018-08-01 /pmc/articles/PMC6212665/ /pubmed/30397372 http://dx.doi.org/10.5005/jp-journals-10005-1528 Text en Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Original Article Reddy, Veerakishore K Kommineni, Naveen K Padakandla, Prathyusha Togaru, Harshini Indupalli, John P Nanga, Swapna P Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome |
title | Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome |
title_full | Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome |
title_fullStr | Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome |
title_full_unstemmed | Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome |
title_short | Evaluation of Chemokines in the Gingival Crevicular Fluid of Children with Down Syndrome |
title_sort | evaluation of chemokines in the gingival crevicular fluid of children with down syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212665/ https://www.ncbi.nlm.nih.gov/pubmed/30397372 http://dx.doi.org/10.5005/jp-journals-10005-1528 |
work_keys_str_mv | AT reddyveerakishorek evaluationofchemokinesinthegingivalcrevicularfluidofchildrenwithdownsyndrome AT kommineninaveenk evaluationofchemokinesinthegingivalcrevicularfluidofchildrenwithdownsyndrome AT padakandlaprathyusha evaluationofchemokinesinthegingivalcrevicularfluidofchildrenwithdownsyndrome AT togaruharshini evaluationofchemokinesinthegingivalcrevicularfluidofchildrenwithdownsyndrome AT indupallijohnp evaluationofchemokinesinthegingivalcrevicularfluidofchildrenwithdownsyndrome AT nangaswapnap evaluationofchemokinesinthegingivalcrevicularfluidofchildrenwithdownsyndrome |